Skip to content

Teknimed

MedTech·France·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Teknimed?

Teknimed is a French MedTech company, currently owned by Apheon since 2026 and 2 other investors.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Apheon
Most recent investor
Apheon
AMB VI · 2025 · Buyout
4 ownership periods · full history below

Key facts

HQFrance
SectorMedTech

Ownership history

3 ownership periods · co-invest detected · 1 lender on file

Active
Co-held by Multicroissance, Essling Capital and Apheon since 2015.
Co-invest · 2 holders · 1 lender · 2015 · present
Multicroissance
2015 · present(11yr) · Multicroissance SAS SCR · 1991 · Growth
Essling Capital
2021 · present(5yr) · Essling Expansion · 2019 · Growth
Apera Asset Management
2021 · present(5yr) · Apera Capital Private Debt Fund I · 2019 · Private Debt
Apheon
ApheonActive
2026 · present(<1yr) · AMB VI · 2025 · Buyout

Questions

Who owns Teknimed?

Teknimed is currently owned by Apheon, Essling Capital and 1 other, through AMB VI, since 2026.

When did Apheon and 2 others acquire Teknimed?

Apheon and 2 others acquired Teknimed in 2026.

Who has owned Teknimed over time?

Teknimed has been through 4 private-equity ownership periods: Multicroissance · via Multicroissance SAS SCR · since 2015; Apera Asset Management · via Apera Capital Private Debt Fund I · since 2021; Essling Capital · via Essling Expansion · since 2021; Apheon · via AMB VI · since 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue